BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS
BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 23, 2023
Expiration Date: March 23, 2024
Description:
Lower-risk myelodysplastic syndromes (LR-MDS) comprise a heterogeneous set of hematologic malignancies characterized by hallmark cytopenias that can lead to significant transfusion burden. New treatment options and best practices are poised to alter the standard of care for LR-MDS.
This activity focuses on emerging treatment options in development to address transfusion burden and disease modification in patients with LR-MDS. This material is supplemented by interviews with expert faculty, who provide insights into the potential impact of these emerging treatments and ways that they may be applied.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Explain unmet clinical needs among patients with LR-MDS related to transfusion dependence
• Determine current approaches to manage LR-MDS in the context of their impact on transfusion dependence
• Describe emerging evidence concerning novel approaches to address transfusion dependence among patients with MDS relapsed/refractory to ESAs.